Why the study?
The prognostic relevance and prevalence of pericardial effusion across several diseases were not well established.
Does the presence of pericardial effusion increase the risk of all-cause mortality in patients with various underlying diseases?
Does the presence of pericardial effusion increase the risk of all-cause mortality in patients with various underlying diseases?
Pericardial effusion is a significant negative prognostic marker associated with increased all-cause mortality across various underlying diseases, including pulmonary hypertension, heart failure, myocardial infarction, and malignancies.
Answers are grounded in this paper and cite their sources.
May inform etiology-specific risk stratification in pericardial effusion; leaves open prospective validation before guiding practice.
BACKGROUND: The prognostic relevance and the prevalence of pericardial effusion in several diseases are not well established. The aim of this meta-analysis is to summarize the available evidence related to pericardial effusion prevalence and outcomes according to the cause. METHODS: Articles investigating the prognosis of pericardial effusion were identified by literature search. Twenty-three studies were finally included (17 022 patients). All-cause mortality was the primary end-point. Secondary end-point was the prevalence of pericardial effusion in most common diseases related to this clinical condition. RESULTS: The pooled prevalence of pericardial effusion was 19.5% [95% confidence interval (CI): 14.3-26]. After a mean follow-up of 36 ± 23 months, the risk of death was higher in pericardial effusion patients [hazard ratio (HR) 1.59, 95% CI 1.37-1.85, P < 0.0001]. Stratifying for the main disease, pericardial effusion is associated with unfavourable outcome in all available subgroups: pulmonary arterial hypertension HR 1.53 (95% CI: 1.22-1.92; P < 0.0001), chronic heart failure (CHF) HR 1.53 (95% CI: 1.22-1.92; P < 0.0001), myocardial infarction HR 2.65 (95% CI: 1.4-4.99; P = 0.003) and malignancies HR 1.75 (95% CI: 1.09-2.81, P = 0.021). The lack of data concerning the idiopathic pericardial effusion does not permit a secure risk assessment but the average incidence of mortality is 14.5% (95% CI: 7.7-25.6). CONCLUSION: Pericardial effusion should be considered a marker of the severity of the underlying disease, whereas for idiopathic pericardial effusion the correlation with poor prognosis is less clear.
No takes yet. Share an insight, caveat, or question.
Filippo et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: